Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response
Molecular and Cellular Proteomics - United States
doi 10.1074/mcp.m117.067439
Full Text
Open PDFAbstract
Available in full text
Date
March 22, 2017
Authors
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)